Literature DB >> 11159514

Telomere length in leukocyte subpopulations of patients with aplastic anemia.

T H Brümmendorf1, J P Maciejewski, J Mak, N S Young, P M Lansdorp.   

Abstract

In most human cells, the average length of telomere repeats at the ends of chromosomes provides indirect information about their mitotic history. To study the turnover of stem cells in patients with bone marrow failure syndromes, the telomere length in peripheral blood granulocytes and lymphocytes from patients with aplastic anemia (AA, n = 56) and hemolytic paroxysmal nocturnal hemoglobinuria (n = 6) was analyzed relative to age-matched controls by means of fluorescence in situ hybridization and flow cytometry. The telomere lengths in granulocytes from patients with AA were found to be significantly shorter than those in age-adjusted controls (P =.001). However, surprisingly, telomere length in granulocytes from AA patients who had recovered after immunosuppressive therapy did not differ significantly from controls, whereas untreated patients and nonresponders with persistent severe pancytopenia showed marked and significant telomere shortening. These results support extensive proliferation of hematopoietic stem cells in subgroups of AA patients. Because normal individuals show significant variation in telomere length, individual measurements in blood cells from AA patients may be of limited value. Whether sequential telomere length measurements can be used as a prognostic tool in this group of disorders remains to be clarified. (Blood. 2001;97:895-900)

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11159514     DOI: 10.1182/blood.v97.4.895

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  60 in total

Review 1.  Anemia of Central Origin.

Authors:  Kazusa Ishii; Neal S Young
Journal:  Semin Hematol       Date:  2015-07-09       Impact factor: 3.851

2.  Paroxysmal nocturnal hemoglobinuria and telomere length predicts response to immunosuppressive therapy in pediatric aplastic anemia.

Authors:  Atsushi Narita; Hideki Muramatsu; Yuko Sekiya; Yusuke Okuno; Hirotoshi Sakaguchi; Nobuhiro Nishio; Nao Yoshida; Xinan Wang; Yinyan Xu; Nozomu Kawashima; Sayoko Doisaki; Asahito Hama; Yoshiyuki Takahashi; Kazuko Kudo; Hiroshi Moritake; Masao Kobayashi; Ryoji Kobayashi; Etsuro Ito; Hiromasa Yabe; Shouichi Ohga; Akira Ohara; Seiji Kojima
Journal:  Haematologica       Date:  2015-08-27       Impact factor: 9.941

3.  Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network, March 2010.

Authors:  Michael A Pulsipher; Neal S Young; Jakub Tolar; Antonio M Risitano; H Joachim Deeg; Paolo Anderlini; Rodrigo Calado; Seiji Kojima; Mary Eapen; Richard Harris; Phillip Scheinberg; Sharon Savage; Jaroslaw P Maciejewski; Ramon V Tiu; Nancy DiFronzo; Mary M Horowitz; Joseph H Antin
Journal:  Biol Blood Marrow Transplant       Date:  2010-10-27       Impact factor: 5.742

Review 4.  Dyskeratosis congenita: a disorder of defective telomere maintenance?

Authors:  Amanda J Walne; Anna Marrone; Inderjeet Dokal
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

Review 5.  Senescence of hematopoietic stem cells and bone marrow failure.

Authors:  Jichun Chen
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

6.  Cord blood telomere shortening associates with increased gestational age and birth weight in preterm neonates.

Authors:  Nora Tabea Sibert; Mónica S Ventura Ferreira; Wolfgang Wagner; Monika Eipel; Stephan Dreschers; Tim H Brümmendorf; Thorsten Orlikowsky; Fabian Beier
Journal:  Exp Ther Med       Date:  2021-02-10       Impact factor: 2.447

7.  Essential roles for Pot1b in HSC self-renewal and survival.

Authors:  Yang Wang; Mei-Feng Shen; Sandy Chang
Journal:  Blood       Date:  2011-09-23       Impact factor: 22.113

8.  Peripheral blood lymphocyte telomere length as a predictor of response to immunosuppressive therapy in childhood aplastic anemia.

Authors:  Hirotoshi Sakaguchi; Nobuhiro Nishio; Asahito Hama; Nozomu Kawashima; Xinan Wang; Atsushi Narita; Sayoko Doisaki; Yinyan Xu; Hideki Muramatsu; Nao Yoshida; Yoshiyuki Takahashi; Kazuko Kudo; Hiroshi Moritake; Kazuhiro Nakamura; Ryoji Kobayashi; Etsuro Ito; Hiromasa Yabe; Shouichi Ohga; Akira Ohara; Seiji Kojima
Journal:  Haematologica       Date:  2014-05-09       Impact factor: 9.941

Review 9.  Telomere diseases.

Authors:  Rodrigo T Calado; Neal S Young
Journal:  N Engl J Med       Date:  2009-12-10       Impact factor: 91.245

10.  Mutations in the SBDS gene in acquired aplastic anemia.

Authors:  Rodrigo T Calado; Solomon A Graf; Keisha L Wilkerson; Sachiko Kajigaya; Philip J Ancliff; Yigal Dror; Stephen J Chanock; Peter M Lansdorp; Neal S Young
Journal:  Blood       Date:  2007-05-03       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.